India made TPA licences perpetual and put a resident-Indian officer at the top of every foreign-owned one.
On 30 July 2026 IRDAI made India's TPA licences perpetual, set a ₹50,000 annual fee, and required a resident-Indian Chair or CEO for foreign-majority TPAs. Each moves a deal.
What a board member needs before the next meeting on this.
- TPA licences are now perpetual. The fixed renewal term is gone; a certificate stays in force as long as the ₹50,000 annual fee is paid by 31 January. Renewal risk buyers used to discount for is off the table.
- A foreign-majority TPA needs a resident Indian at the top. The Chairperson, or the CEO / Principal Officer / MD, must be a resident Indian citizen at all times. A foreign buyer's control slate has to seat one.
- The fee is trivial; the mechanism is a covenant. ₹50,000 plus tax by 31 Jan, 2% interest to 31 Mar, then non-payment is a breach that permits suspension or cancellation. It reads like a covenant, not a fee.
- Related-party transactions now report quarterly. Captive TPA–insurer structures publish RPT details quarterly plus annual audited accounts on the website. The disclosure changes what a captive can keep quiet.
India's third-party administrators sit in the plumbing of health insurance. They run the claims networks and hold the data. They are also a live deal category: Medi Assist is listed, other TPAs have changed hands, and every large health insurer either owns one or leans on one. On 30 July 2026 the IRDAI notified the Third Party Administrators (Health Services) (Amendment) Regulations, 2026 (F.No. IRDAI/Reg/12/226/2026), and it moves several things a buyer prices.
The licence is now perpetual, which quietly removes a discount
Under the old regime a TPA registration ran for a fixed term and had to be renewed. The amendment replaces that with a certificate that stays in force as long as the TPA pays its annual fee and stays compliant. Renewal was a periodic risk a careful buyer modelled: the chance, however small, that a licence lapses or a renewal attaches new conditions. That risk is gone. For a target whose value is the licence and the network behind it, perpetual registration raises the floor on what the licence is worth, and a seller who has not repriced against it is leaving that on the table.
A foreign-majority TPA now needs a resident Indian at the top
This is the clause that reshapes a control deal. Where foreign shareholding is in the majority, the amendment requires that either the Chairperson of the board, or the Chief Executive Officer, Principal Officer or Managing Director, is a resident Indian citizen at all times. A GCC fund or an overseas strategic taking majority control of an Indian TPA cannot simply install its own slate. It has to seat a resident-Indian officer in one of those roles and keep one there. That is a governance constraint and a diligence question about whether the current structure already complies or has to be rebuilt on day one.
The annual fee is small; the mechanism behind it is a covenant
The fee itself is ₹50,000 plus applicable taxes, payable by 31 January each year, which is trivial against a TPA's revenue. What matters is what sits around it. Pay between 1 February and 31 March and 2% interest applies. Miss 31 March and the non-payment is a breach that permits suspension or cancellation of the registration. A routine fee is wired to the licence itself. In diligence this is not a cost line, it is a compliance covenant, and a patchy payment history is a red flag that goes to the survival of the asset, not its margin.
Related-party transactions move into quarterly daylight
Many Indian TPAs sit inside a group that also owns or controls an insurer, and the flows between the two are where value and conflicts both live. The amendment requires related-party transaction details on a quarterly basis, alongside annual audited financials, published on the TPA's website. For a captive structure that has reported lightly, that changes what can stay quiet, and a buyer reading those disclosures gets a clearer view of how much of the TPA's economics depend on a related insurer.
What the amendment left for later
The exposure draft floated letting TPAs list their equity. That provision was held back for future consideration, so a TPA IPO is not on the table under this notification. It is worth knowing precisely because the draft raised it: the listing route is signposted, not open, and anyone modelling an exit through a public market is modelling something the regulator has parked.
Four questions before an India TPA deal
- Does the target's certificate convert cleanly to the perpetual regime, and is the annual fee current?
- If we take majority control, who is our resident-Indian Chairperson or CEO / Principal Officer / MD?
- What related-party flows between the TPA and any affiliated insurer now surface in quarterly disclosure?
- Has the target aligned with the Sabka Bima Sabki Raksha Act 2025 obligations this amendment implements?
The amendment implements the Sabka Bima Sabki Raksha Act, 2025, the wider insurance-law overhaul, so it is a direction rather than a one-off tweak. For anyone holding or chasing an Indian TPA, the near-term work is concrete: confirm the certificate has moved onto the perpetual footing with the fee current, and identify who the resident-Indian officer is under new ownership before reading the last few quarters of related-party disclosure. That structuring and diligence work is where our transactions and capital practice begins.